Topics

Catalent Completes MaSTherCell Acquisition

04:00 EST 11 Feb 2020 | Contract Pharma

Technology-focused cell and gene therapy CDMO adds unique portfolio of capabilities and technologies

Original Article: Catalent Completes MaSTherCell Acquisition

NEXT ARTICLE

More From BioPortfolio on "Catalent Completes MaSTherCell Acquisition"

Quick Search

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...